Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep:110:93-94.
doi: 10.1016/j.ijid.2021.07.050. Epub 2021 Jul 26.

A five-day course of ivermectin may reduce the duration of COVID-19 illness

Sabeena Ahmed  1 , Wasif Ali Khan  2
Affiliations
Comment

A five-day course of ivermectin may reduce the duration of COVID-19 illness

Sabeena Ahmed et al. Int J Infect Dis. 2021 Sep.
No abstract available

Keywords: COVID-19; antiviral effect; ivermectin.

PubMed Disclaimer

Conflict of interest statement

None declared

Comment on

References

    1. Ahmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, et al. A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int J Infect Dis. 2021;103:214–216. doi: 10.1016/j.ijid.2020.11.191. - DOI - PMC - PubMed
    1. González Canga A, Sahagún Prieto AM, Diez Liébana MJ, Fernández Martínez N, Sierra Vega M, García Vieitez JJ. The pharmacokinetics and interactions of ivermectin in humans — a mini-review. Aaps j. 2008;10(1):42–46. doi: 10.1208/s12248-007-9000-9. - DOI - PMC - PubMed
    1. Suputtamongkol Y, Avirutnan P, Mairiang D, Angkasekwinai N, Niwattayakul K, Yamasmith E, et al. Ivermectin accelerates circulating nonstructural protein 1 (NS1) clearance in adult dengue patients: a combined phase 2/3 randomized double-blinded placebo controlled trial. Clin Infect Dis. 2021;72(16 June 2021):e586–ee93. doi: 10.1093/cid/ciaa1332. - DOI - PubMed
    1. Hariyanto TI, Halim DA, Rosalind J, Gunawan C, Kurniawan A. Ivermectin and outcomes from COVID-19 pneumonia: a systematic review and meta-analysis of randomized clinical trial studies. Rev Med Virol. 2021:e2265. doi: 10.1002/rmv.2265. n/a(n/a) - DOI
    1. Zhang X, Song Y, Ci X, An N, Ju Y, Li H, et al. Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice. Inflamm Res. 2008;57(11):524–529. doi: 10.1007/s00011-008-8007-8. - DOI - PubMed